Treatment of Rodent Liver Tumor With Combretastatin A4 Phosphate-Reference-Cited by-同舟云学术

Treatment of Rodent Liver Tumor With Combretastatin A4 Phosphate

Published:2009-01 Issue:1 Volume:44 Page:44-53
ISSN:0020-9996
Container-title:Investigative Radiology
language:en
Short-container-title:Investigative Radiology

Author:

Wang Huaijun,Sun Xihe,Chen Feng,De Keyzer Frederik,Yu Jie,Landuyt Willy,Vandecaveye Vincent,Peeters Ronald,Bosmans Hilde,Hermans Robert,Marchal Guy,Ni Yicheng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference40 articles.

1. Vascular Targeting Agents as Cancer Therapeutics

2. Vascular-targeting therapies for treatment of malignant disease

3. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4

4. The biology of the combretastatins as tumour vascular targeting agents

5. The interaction with tubulin of a series of stilbenes based on combretastatin A-4

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combretastatins A-4 and A-1 and their derivatives: Review;Russian Journal of Biotherapy;2024-03-22

2. Acceptor engineering for NIR-II dyes with high photochemical and biomedical performance;Nature Communications;2022-07-02

3. A high‐throughput and simultaneous determination of combretastatin A‐4 phosphate and its metabolites in human plasma using HPLC–MS/MS: Application to a clinical pharmacokinetic study;Biomedical Chromatography;2021-07-06

4. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors;Molecules;2021-04-27

5. Combretastatin A-4 disodium phosphate and low dose gamma irradiation suppress hepatocellular carcinoma by downregulating ROCK1 and VEGF gene expression;Molecular Biology Reports;2020-02-03